GI Treatment in Rural Areas & Additional Dementia Caring Cost for Neurologically-linked GI Commorbidities

When the Gut and Brain Both Need Help—but the Clinic Is Far Away

Imagine an 82-year-old farmer in a rural county who has Alzheimer’s and chronic constipation, wakes up some days with reflux, and occasionally chokes on food. None of those issues on their own sound dramatic. But together they can mean ER trips for GI bleeding, aspiration pneumonia, or dehydration—while a specialist who understands both gut and brain is more than an hour’s drive away. That’s the lived reality behind a growing but still under-discussed problem: GI treatment in rural areas and the extra dementia care costs driven by neurologically linked GI comorbidities.

1. GI care in rural areas: distance, delay, and workarounds

At a systems level, the first barrier is brutally simple: there often is no gastroenterologist nearby.

A 2025 analysis of U.S. physician workforce data found that almost 50 million Americans—disproportionately in rural counties—must travel at least 25 miles to see a gastroenterologist, and over two-thirds of U.S. counties have no gastroenterologist at all. About 80% of these “GI-desert” counties are non-metropolitan, older, poorer, and less insured than counties with a specialist.

Where there are no GI doctors, rural systems improvise. A qualitative study of colonoscopy provision in rural Oregon showed that much of the endoscopy work is done by primary-care physicians and general surgeons who scope their own patients or accept referrals, often for Medicaid populations. Providers described multilevel barriers—travel, time off work, fear of costs, and shrinking numbers of primary-care endoscopists—as threats to sustaining access. Earlier work showed that rural residency is associated with fewer colonoscopy providers overall, longer waits, and decreased utilization, even when patients are eligible for screening.

All of this matters because chronic GI disease is not “cheap.” In the U.S., chronic GI and liver diseases account for heavy hospitalization and cost burdens, including billions annually for upper GI bleeding and hundreds of thousands of admissions. For older adults, common issues like dyspepsia, GERD, constipation, fecal incontinence, and motility problems are highly prevalent and often more severe or more complicated than in younger patients. When those problems go underdiagnosed or undertreated in rural settings—because there’s no endoscopist, no motility lab, no easy follow-up—they quietly accumulate risk.

2. The gut–brain axis: why GI problems are not “separate” from dementia

Over the last decade, the microbiota–gut–brain axis has shifted how we think about GI disease and neurodegeneration. Reviews in Signal Transduction and Targeted Therapy and related journals describe a bidirectional network in which gut microbes, immune signaling, and the vagus nerve influence microglial activation, neuroinflammation, and synaptic function, making the gut a real lever for neurodegenerative disease pathways.

Epidemiologic data are now catching up. A large prospective cohort study in American Journal of Preventive Medicinefound that eleven digestive system diseases—including cirrhosis, peptic ulcer disease, and inflammatory bowel disease—were significantly associated with higher incident dementia risk after adjusting for genetics and vascular factors. A meta-analysis focusing specifically on inflammatory bowel disease (IBD) reported that IBD is associated with increased all-cause dementia risk, though estimates vary and more prospective data are needed.

Other work links slower, more “everyday” GI problems to brain outcomes: research presented at the Alzheimer’s Association International Conference in 2023 showed that less frequent bowel movements in mid- to late life were associated with faster cognitive decline.

So when a rural dementia patient has chronic constipation, reflux, IBD, dyspepsia, or chronic GI bleeding, those aren’t just side quests. They sit right inside the gut–brain loop that influences inflammation, nutrition, mood, and ultimately dementia trajectory.

3. Dementia is already expensive—multimorbidity makes it worse

Even without GI problems, dementia is one of the most expensive conditions in the world. Hurd and colleagues estimated that in 2010, dementia added roughly $33,000 per person per year in extra health-care costs in the United States, with total national costs (including informal care) in the $159–215 billion range. Global modeling suggests direct costs could reach around $2 trillion by 2030 if trends continue.

Claims–based studies consistently show that people with Alzheimer’s disease (AD) or related dementias have more comorbid medical conditions and higher Medicare expenditures than similar older adults without dementia.When you add Medicaid, the spending gap widens further: in one ethnically diverse cohort, annual Medicaid expenditures for people with dementia averaged about $50,000 versus $22,000 for those without dementia, with combined Medicare–Medicaid spending nearly double.

Recent work in England found that “high-cost” AD dementia subgroups—characterized by greater frailty and more cardiometabolic comorbidities—spent 1.3–1.7 times the average per-person cost, with social care dominating the bill.Behavioral symptoms, agitation, and other complications also significantly increase health-care utilization and cost.

Taken together, the literature is clear on one point: comorbidities are cost multipliers in dementia.

4. GI comorbidities as hidden cost drivers in dementia care

Where the evidence is thinner—but emerging—is the specific role of GI comorbidities in those costs.

Dysphagia (swallowing difficulty) is a good example. In general geriatric populations, dysphagia is associated with higher hospital and municipal care costs; one Danish study estimated that older adults with dysphagia incurred roughly €3,700 more in hospital costs and over €6,000 more in municipal health-care costs per year than those without, even after adjusting for age and comorbidities. Systematic reviews in Alzheimer’s disease show that dysphagia prevalence rises dramatically with disease severity and is linked to aspiration pneumonia, malnutrition, institutionalization, and increased overall health-care costs.

A 2023 ICU-based study of older adults with dementia found that those with dysphagia had significantly higher 90- and 180-day mortality, more pressure injuries, more aspiration pneumonia, and were more often discharged to nursing facilities rather than home—all of which are cost-intensive outcomes.

Other GI problems create similar financial drag. Chronic GI and liver diseases generate high rates of hospitalization and billions in direct costs annually. In older adults with dementia, colonoscopy appears technically feasible but is associated with longer length of stay, more non-GI complications (like kidney injury and pneumonia), and higher hospital costs compared to patients without dementia.

If you overlay that on the earlier dementia-cost picture, the story becomes:

• Dementia itself is expensive;

• Multimorbidity, frailty, and complications push selected subgroups into very high-cost tiers;

• GI comorbidities—especially dysphagia, IBD, bleeding, and motility disorders—are common in older adults, bi-directionally linked to brain health, and associated with greater hospital use, institutionalization, and supportive care needs.

There are not yet many papers that compute “the exact extra dollars of dementia care attributable to neurologically linked GI comorbidities.” But the pieces we do have strongly imply that these conditions add a substantial incremental burden, particularly via hospitalizations, long-term care placements, and caregiver time.

5. Why rural GI gaps amplify dementia costs

Now put all of this back into a rural setting:

• Fewer specialists and longer travel distances mean delayed diagnosis of dysphagia, IBD, or GI bleeding. That can mean presenting late with severe anemia, perforation, or aspiration pneumonia rather than catching issues in outpatient care.

• Limited endoscopy and motility capacity restrict screening and therapeutic options, including PEG placement, dilation for strictures, or endoscopic control of bleeding.

• Fragmented services—no local speech–language pathologist, no dietitian experienced in dementia, no home-based swallow therapy—push management toward hospitalization and institutional care instead of community-based prevention.

• Caregiver and travel burdens are higher: rural family members lose days of work to drive patients to distant GI centers, navigate complex prep instructions with someone who has cognitive impairment, and then manage post-procedure complications at home.

Meanwhile, dementia care is already absorbing huge amounts of unpaid labor: in 2024, unpaid dementia caregiving in the U.S. was valued at over $400 billion, on top of formal health-care and social-care expenditures. When GI comorbidities add extra trips, feeding challenges, toileting problems, or aspiration events, those costs get paid partly in dollars and partly in exhausted hours.

From a systems perspective, you can think of neurologically linked GI comorbidities as a force multiplier on dementia costs in rural areas:

• They are more common and more severe in older populations.

• They directly worsen nutrition, immune status, and infection risk.

• They demand specialist care that rural systems are least equipped to provide.

6. Where the literature is pointing

If you zoom out, the combined GI–dementia literature is quietly arguing for three things:

1. Better rural GI infrastructure and task-sharing – training primary-care clinicians, nurse practitioners, and physician assistants in basic endoscopy and dysphagia management; supporting tele-GI and tele-swallow services; and aligning reimbursement so this work is sustainable in low-volume settings.

2. Early, gut-focused dementia prevention and care – using what we know about the microbiota–gut–brain axis and GI–dementia risk to intervene earlier on constipation, IBD, liver disease, and bleeding in midlife, especially in rural cohorts.

3. Cost models that explicitly include GI comorbidities – current dementia cost estimates mostly treat “other chronic diseases” as a lump. Pulling GI conditions out as a named category—like we now do for cardiometabolic disease—would help quantify how much money (and caregiver time) is being lost to untreated or poorly treated gut–brain issues.

Those changes translate into fewer emergencies, more care at home, and caregivers who are spending their time on meaningful support instead of preventable crises. The science is already telling us the gut and brain are inseparable. Policy and service design in rural health are still catching up.

References

Cheng, H., et al. (2023). Associations between dysphagia and adverse health outcomes in older adults with dementia in intensive care units. Clinical Interventions in Aging, 18, 1543–1557.

Gallo, A., et al. (2024). Main disorders of gastrointestinal tract in older people: An overview. Geriatrics, 6(1), 22.

Hurd, M. D., Martorell, P., Delavande, A., Mullen, K. J., & Langa, K. M. (2013). Monetary costs of dementia in the United States. New England Journal of Medicine, 368(14), 1326–1334.

Liu, N., et al. (2022). Inflammatory bowel disease and risk of dementia: An updated meta-analysis. Frontiers in Aging Neuroscience, 14, 962681.

Loh, J. S., et al. (2024). Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduction and Targeted Therapy, 9, 66.

MacNeil-Vroomen, J. L., et al. (2020). Health-care use and cost for multimorbid persons with dementia. Alzheimer’s & Dementia, 16(12), 1748–1757.

Nguyen, N. H., et al. (2018). Annual burden and costs of hospitalization for high-need patients with chronic gastrointestinal and liver diseases. Clinical Gastroenterology and Hepatology, 16(7), 1031–1041.e3.

Nandi, A., et al. (2022). Global and regional projections of the economic burden of Alzheimer’s disease and related dementias from 2019 to 2050. EClinicalMedicine, 51, 101580.

Ramalingam, N. P., et al. (2024). Provision of colonoscopy in rural settings: A qualitative assessment of provider context, barriers, facilitators, and capacity. Journal of Rural Health, 40(2), 272–281.

Sun, Y., et al. (2019). The gut microbiome as a therapeutic target for cognitive impairment. Journal of the Neurological Sciences, 400, 85–92.

Weill Cornell Medicine. (2025). Many Americans lack access to a gastroenterologist. Press release / news article, February 6, 2025.

Westmark, S., et al. (2018). The cost of dysphagia in geriatric patients. Clinical Interventions in Aging, 13, 1341–1349.

Yuan, S., et al. (2024). Digestive system diseases, genetic risk, and incident dementia: A prospective cohort study. American Journal of Preventive Medicine, 66(3), 516–525.

Zhao, Y., et al. (2008). Healthcare costs and utilization for Medicare beneficiaries with Alzheimer’s disease. Journal of the American Geriatrics Society, 56(12), 2190–2196.

Zhu, C. W., et al. (2020). Medicaid contributes substantial costs to dementia care in an ethnically diverse community. Journals of Gerontology: Series B, 75(7), 1527–1537.